TG
BIVV

TLP Group’s Bioverativ Inc. Common Stock BIVV Stock Holding History

TLP Group’s Portfolio BIVV Stock Details BIVV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-197
Closed -$11K – 708
2017
Q4 		$11K Buy
+197
New +$10.8K 0.01% 369

Other funds holding BIVV

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
ACS
Archford Capital Strategies Swansea, Illinois $987M AUM 29.31% 1-Year Est. Return

TLP Group's BIVV Position: Q1 2018 in Review

TLP Group sold out of Bioverativ Inc. Common Stock (BIVV) in Q1 2018, closing a stake of 197 shares — an estimated $11K sold.

TLP Group first reported a position in BIVV in Q4 2017 and held it in 1 quarter. The position peaked at $11K in Q4 2017. 2 funds tracked by Wall St. Rank hold BIVV as of Q1 2018.

  • TLP Group reported no remaining Bioverativ Inc. Common Stock position as of Q1 2018 after selling out during the quarter.
  • TLP Group sold 197 Bioverativ Inc. Common Stock shares in Q1 2018, an estimated $11K.
  • TLP Group first reported a position in Bioverativ Inc. Common Stock in Q4 2017 and held it in 1 quarter.
  • TLP Group's Bioverativ Inc. Common Stock position peaked at $11K in Q4 2017.
  • 2 funds tracked by Wall St. Rank held Bioverativ Inc. Common Stock as of Q1 2018.

Based on TLP Group's 13F filing for Q1 2018, filed 16 May 2018.